19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Brain metabolic sensing and metabolic signaling at the level of an astrocyte

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Astrocytes support neuronal function by providing essential structural and nutritional support, neurotransmitter trafficking and recycling and may also contribute to brain information processing. In this article we review published results and report new data suggesting that astrocytes function as versatile metabolic sensors of central nervous system (CNS) milieu and play an important role in the maintenance of brain metabolic homeostasis. We discuss anatomical and functional features of astrocytes that allow them to detect and respond to changes in the brain parenchymal levels of metabolic substrates (oxygen and glucose), and metabolic waste products (carbon dioxide). We report data suggesting that astrocytes are also sensitive to circulating endocrine signals—hormones like ghrelin, glucagon‐like peptide‐1 and leptin, that have a major impact on the CNS mechanisms controlling food intake and energy balance. We discuss signaling mechanisms that mediate communication between astrocytes and neurons and consider how these mechanisms are recruited by astrocytes activated in response to various metabolic challenges. We review experimental data suggesting that astrocytes modulate the activities of the respiratory and autonomic neuronal networks that ensure adaptive changes in breathing and sympathetic drive in order to support the physiological and behavioral demands of the organism in ever‐changing environmental conditions. Finally, we discuss evidence suggesting that altered astroglial function may contribute to the pathogenesis of disparate neurological, respiratory and cardiovascular disorders such as Rett syndrome and systemic arterial hypertension.

          Main Points

          • Astrocytes are versatile CNS sensors capable of detecting various metabolic and endocrine signals.

          • Astrocytes modulate the activities of the brainstem respiratory and autonomic neuronal circuits that ensure metabolic homeostasis.

          Related collections

          Most cited references101

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

          Objective Although Glucagon-like peptide 1 is a key regulator of energy metabolism and food intake, the precise location of GLP-1 receptors and the physiological relevance of certain populations is debatable. This study investigated the novel GLP-1R-Cre mouse as a functional tool to address this question. Methods Mice expressing Cre-recombinase under the Glp1r promoter were crossed with either a ROSA26 eYFP or tdRFP reporter strain to identify GLP-1R expressing cells. Patch-clamp recordings were performed on tdRFP-positive neurons in acute coronal brain slices from adult mice and selective targeting of GLP-1R cells in vivo was achieved using viral gene delivery. Results Large numbers of eYFP or tdRFP immunoreactive cells were found in the circumventricular organs, amygdala, hypothalamic nuclei and the ventrolateral medulla. Smaller numbers were observed in the nucleus of the solitary tract and the thalamic paraventricular nucleus. However, tdRFP positive neurons were also found in areas without preproglucagon-neuronal projections like hippocampus and cortex. GLP-1R cells were not immunoreactive for GFAP or parvalbumin although some were catecholaminergic. GLP-1R expression was confirmed in whole-cell recordings from BNST, hippocampus and PVN, where 100 nM GLP-1 elicited a reversible inward current or depolarisation. Additionally, a unilateral stereotaxic injection of a cre-dependent AAV into the PVN demonstrated that tdRFP-positive cells express cre-recombinase facilitating virally-mediated eYFP expression. Conclusions This study is a comprehensive description and phenotypic analysis of GLP-1R expression in the mouse CNS. We demonstrate the power of combining the GLP-1R-CRE mouse with a virus to generate a selective molecular handle enabling future in vivo investigation as to their physiological importance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A role for glia in the progression of Rett's syndrome.

            Rett's syndrome (RTT) is an X-chromosome-linked autism spectrum disorder caused by loss of function of the transcription factor methyl-CpG-binding protein 2 (MeCP2). Although MeCP2 is expressed in most tissues, loss of MeCP2 expression results primarily in neurological symptoms. Earlier studies suggested the idea that RTT is due exclusively to loss of MeCP2 function in neurons. Although defective neurons clearly underlie the aberrant behaviours, we and others showed recently that the loss of MECP2 from glia negatively influences neurons in a non-cell-autonomous fashion. Here we show that in globally MeCP2-deficient mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged lifespan compared to globally null mice. Furthermore, restoration of MeCP2 in the mutant astrocytes exerted a non-cell-autonomous positive effect on mutant neurons in vivo, restoring normal dendritic morphology and increasing levels of the excitatory glutamate transporter VGLUT1. Our study shows that glia, like neurons, are integral components of the neuropathology of RTT, and supports the targeting of glia as a strategy for improving the associated symptoms.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

              Hypoglycaemia is a frequent adverse effect of treatment of diabetes mellitus with insulin and sulphonylureas. Fear of hypoglycaemia alters self-management of diabetes mellitus and prevents optimal glycaemic control. Mild (self-treated) and severe (requiring help) hypoglycaemia episodes are more common in type 1 diabetes mellitus but people with insulin-treated type 2 diabetes mellitus are also exposed to frequent hypoglycaemic events, many of which occur during sleep. Hypoglycaemia can disrupt many everyday activities such as driving, work performance and leisure pursuits. In addition to accidents and physical injury, the morbidity of hypoglycaemia involves the cardiovascular and central nervous systems. Whereas coma and seizures are well-recognized neurological sequelae of hypoglycaemia, much interest is currently focused on the potential for hypoglycaemia to cause dangerous and life-threatening cardiac complications, such as arrhythmias and myocardial ischaemia, and whether recurrent severe hypoglycaemia can cause permanent cognitive impairment or promote cognitive decline and accelerate the onset of dementia in middle-aged and elderly people with diabetes mellitus. Prevention of hypoglycaemia is an important part of diabetes mellitus management and strategies include patient education, glucose monitoring, appropriate adjustment of diet and medications in relation to everyday circumstances including physical exercise, and the application of new technologies such as real-time continuous glucose monitoring, modified insulin pumps and the artificial pancreas.
                Bookmark

                Author and article information

                Contributors
                n.marina@ucl.ac.uk
                a.gourine@ucl.ac.uk
                Journal
                Glia
                Glia
                10.1002/(ISSN)1098-1136
                GLIA
                Glia
                John Wiley and Sons Inc. (Hoboken )
                0894-1491
                1098-1136
                23 December 2017
                June 2018
                : 66
                : 6 , Glia and Brain Energy Metabolism: New approaches, new insights ( doiID: 10.1002/glia.v66.6 )
                : 1185-1199
                Affiliations
                [ 1 ] Centre for Cardiovascular and Metabolic Neuroscience, Neuroscience, Physiology & Pharmacology University College London London WC1E 6BT United Kingdom
                [ 2 ] Research Department of Metabolism and Experimental Therapeutics, Division of Medicine University College London London WC1E 6JJ United Kingdom
                [ 3 ] Laboratory of Intracellular Signalling Institute of Cell Biophysics, Russian Academy of Sciences Pushchino Russia
                Author notes
                [*] [* ] Correspondence Nephtali Marina, Research Department of Metabolism and Experimental Therapeutics, Division of Medicine, University College London, London WC1E 6JJ, UK. Email: n.marina@ 123456ucl.ac.uk Alexander V. Gourine, Neuroscience, Physiology & Pharmacology, University College London, London WC1E 6BT, UK. Email: a.gourine@ 123456ucl.ac.uk
                Author information
                http://orcid.org/0000-0001-9921-660X
                http://orcid.org/0000-0003-4119-9979
                http://orcid.org/0000-0003-3068-491X
                Article
                GLIA23283
                10.1002/glia.23283
                5947829
                29274121
                cf12a5d6-7570-4246-a131-4a9b33ef0a1a
                © 2017 The Authors GLIA Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 01 June 2017
                : 04 October 2017
                : 29 November 2017
                Page count
                Figures: 5, Tables: 0, Pages: 15, Words: 12245
                Funding
                Funded by: Medical Research Council
                Award ID: MR/N02589X/1
                Funded by: Wellcome Trust
                Award ID: 095064
                Award ID: 200893
                Funded by: British Heart Foundation
                Award ID: FS/13/5/29927
                Award ID: RG/14/4/30736
                Categories
                Review Article
                REVIEW ARTICLES
                Glial Specific Contributions to Brain Energy Metabolism
                Custom metadata
                2.0
                glia23283
                June 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.8.2 mode:remove_FC converted:11.05.2018

                Neurosciences
                brainstem,breathing,chemoreception,food intake,gut hormone,metabolism
                Neurosciences
                brainstem, breathing, chemoreception, food intake, gut hormone, metabolism

                Comments

                Comment on this article